June 24, 2018 5:52 PM ET

Biotechnology

Company Overview of Targeted Diagnostics & Therapeutics, Inc.

Key Executives for Targeted Diagnostics & Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Harry A. Arena 4 RelationshipsChairman of the Board, Chief Executive Officer and President--
David D. Gathman CPA32 RelationshipsChief Financial Officer and Vice President69
Daniel J. O'Shannessy Ph.D.No RelationshipsChief Operating Officer --
Alan D. Watson Ph.D., M.B.A6 RelationshipsChief Business Officer and Executive Vice President64
Arthur V. Boyce Jr.No RelationshipsVice President of Marketing and Business Development--

Targeted Diagnostics & Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Harry A. Arena 4 RelationshipsTargeted Diagnostics & Therapeutics, Inc.--
Scott A. Waldman M.D., Ph.D. 4 RelationshipsTargeted Diagnostics & Therapeutics, Inc.--
Andre Terzic M.D., Ph.D. 4 RelationshipsMayo Clinic Health System New Prague--
John L. Marshall M.D. 29 RelationshipsCaris Life Sciences, Inc.--
Anil K. Rustgi M.D. 52 RelationshipsTargeted Diagnostics & Therapeutics, Inc.--
View All Board Members

Targeted Diagnostics & Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Scott A. Waldman4 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
444.3K
Bonus
265.9K
Total Short Term Compensation
412.4K
Total Value of Options
14.2M
Compensation as of Fiscal Year
Targeted Diagnostics & Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Trovagene Announces Executive Changes
June 22, 2018 9:19 PM ET
Aevi Genomic Medicine, Inc. Announces the Retirement of Wilbur H. Gantz's from the Board of Directors and Audit Committee
June 22, 2018 9:15 PM ET
Neurotrope, Inc. Announces Resignation of Andrew Perlman as Board of Director
June 22, 2018 8:30 PM ET
Fibrocell Science, Inc. Appoints Sean D. Buckley as Vice President of Business Administration and Corporate Secretary
June 22, 2018 8:08 PM ET
Altimmune, Inc. Announces That Derace Schaffer Will Not Stand for Reelection as Member of the Board
June 22, 2018 8:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Targeted Diagnostics & Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.